GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
2.150
+0.030 (1.42%)
Feb 21, 2025, 4:00 PM EST - Market closed
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $4.80 million as of February 21, 2025. Its market cap has decreased by -28.55% in one year.
Market Cap
4.80M
Enterprise Value
852.81K
1-Year Change
-28.55%
Ranking
Category
Stock Price
$2.15
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $4.80M, a decrease of -99.49%. That is a compound annual growth rate of -11.97%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.21B |
| UnitedHealth Group | 462.37B |
| Johnson & Johnson | 384.45B |
| Novo Nordisk | 370.84B |
| AbbVie | 354.62B |
| Abbott Laboratories | 230.98B |
| AstraZeneca | 227.07B |
| Merck & Co. | 221.80B |